In the treatment of symptomatic intracranial aneurysms,the study by Zhao et al stands as a notable addition to the growing body of literature.^(1) Their investigation regarding the Pipeline Embolisation Device’s(PED,...In the treatment of symptomatic intracranial aneurysms,the study by Zhao et al stands as a notable addition to the growing body of literature.^(1) Their investigation regarding the Pipeline Embolisation Device’s(PED,Covi-dien/Medtronic,Irvine,California,USA)effi-cacy in alleviating mass effect offers valuable insights that further contribute to the evolving landscape of neurointerventional therapy.We applaud the authors for their dedicated efforts in tackling an essential facet of aneu-rysm management.Engaging with studies involving extensive cohorts is always enlight-ening,as they ignite discussions and open avenues for fresh research opportunities.展开更多
文摘In the treatment of symptomatic intracranial aneurysms,the study by Zhao et al stands as a notable addition to the growing body of literature.^(1) Their investigation regarding the Pipeline Embolisation Device’s(PED,Covi-dien/Medtronic,Irvine,California,USA)effi-cacy in alleviating mass effect offers valuable insights that further contribute to the evolving landscape of neurointerventional therapy.We applaud the authors for their dedicated efforts in tackling an essential facet of aneu-rysm management.Engaging with studies involving extensive cohorts is always enlight-ening,as they ignite discussions and open avenues for fresh research opportunities.
